ALPHA3
NOW ENROLLING
The industry's first pivotal Phase 2 first‑line (1L) consolidation trial of an investigational allogeneic CAR T in large-B cell lymphoma (LBCL)
ALPHA3
PIVOTAL PHASE 2 ALPHA3 TRIAL INITIATED
Allogene initiates the industry's first pivotal first line (1L) consolidation trial of an investigational allogeneic CAR T in LBCL